HealthEquity Income Statement

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Revenue	1,337	1,313	1,200	999.59	861.75	756.56
Revenue Growth (YoY)	7.58%	9.47%	20.03%	16.00%	13.90%	3.13%
Cost of Revenue	392.11	400.31	422.52	376.95	369.81	331.79
Gross Profit	945.12	913.12	777.26	622.64	491.94	424.77
Selling, General & Admin	221.62	215.17	223	182.93	166.32	144.04
Depreciation & Amortization Expenses	107.47	107.95	111.88	92.76	94.59	82.79
Research & Development	268.84	262.51	239.51	218.81	193.38	157.36
Other Operating Expenses	4.86	5.02	40.54	10.44	28.6	64.81
Total Operating Expenses	602.79	590.66	614.93	504.94	482.88	449
Operating Income	342.33	322.46	162.33	117.7	9.06	-24.24
Interest Expense	-54.86	-57.13	-60.63	-55.46	-48.42	-36.57
Other Non-Operating Income (Expense)	11.42	12.11	14.33	12.8	1.27	-5.93
Total Non-Operating Income (Expense)	-43.44	-45.02	-46.3	-42.66	-47.15	-42.5
Pretax Income	298.89	277.43	116.03	75.04	-38.1	-66.74
Provision for Income Taxes	68.19	62.23	19.33	19.33	-11.95	-22.45
Net Income	111.55	215.2	96.7	55.71	-26.14	-44.29
Net Income to Common	111.55	215.2	96.7	55.71	-26.14	-44.29
Net Income Growth	168.62%	122.54%	73.58%	-	-	-
Shares Outstanding (Basic)	86	86	87	86	84	83
Shares Outstanding (Diluted)	87	87	89	87	84	83
Shares Change (YoY)	-2.34%	-1.52%	2.15%	2.98%	1.57%	9.85%
EPS (Basic)	2.69	2.50	1.11	0.65	-0.31	-0.53
EPS (Diluted)	2.67	2.46	1.09	0.64	-0.31	-0.53
EPS Growth	94.89%	125.69%	70.31%	-	-	-
Free Cash Flow	487.64	455.13	337.77	241.13	147.28	132.09
Free Cash Flow Growth	7.14%	34.74%	40.08%	63.73%	11.50%	-21.62%
Free Cash Flow Per Share	5.64	5.20	3.80	2.77	1.74	1.59
Gross Margin	70.68%	69.52%	64.78%	62.29%	57.09%	56.14%
Operating Margin	25.60%	24.55%	13.53%	11.77%	1.05%	-3.20%
Profit Margin	8.34%	16.38%	8.06%	5.57%	-3.03%	-5.85%
FCF Margin	36.47%	34.65%	28.15%	24.12%	17.09%	17.46%
EBITDA	496.46	477.11	324.79	270.78	170.26	112.95
EBITDA Margin	37.13%	36.33%	27.07%	27.09%	19.76%	14.93%
EBIT	342.33	322.46	162.33	117.7	9.06	-24.24
EBIT Margin	25.60%	24.55%	13.53%	11.77%	1.05%	-3.20%
Effective Tax Rate	22.81%	22.43%	16.66%	25.76%	31.38%	33.64%

SEC Filings: 10-K · 10-Q